Evidence map›Paper›PMID 27609773›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2016

Plexin C1 deficiency permits synaptotagmin 7-mediated macrophage migration and enhances mammalian lung fibrosis.

Xueyan Peng, Meagan Moore, Aditi Mathur, Yang Zhou, Huanxing Sun, Ye Gan, Jose D Herazo-Maya, Naftali Kaminski, Xinyuan Hu, Hongyi Pan and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 65 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. New Promising Routes in Peptic Ulcers: Toll-like Receptors and Semaphorins.Endocrine, metabolic & immune disorders drug targets · 2024
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Frontiers in cell and developmental biology · 2021
    Article
  18. Article
  19. Review
  20. Evolving Perspectives on Innate Immune Mechanisms of IPF.Frontiers in molecular biosciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 1 country.

Xueyan PengDepartment of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Meagan MooreDepartment of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Aditi MathurDepartment of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Yang ZhouDepartment of Molecular Microbiology and Immunology, Warren Alpert School of Medicine, Brown University, Providence, Rhode Island, USA.
Huanxing SunDepartment of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Ye GanDepartment of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Jose D Herazo-MayaDepartment of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Naftali KaminskiDepartment of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Xinyuan HuDepartment of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Hongyi PanDepartment of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Changwan RyuDepartment of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Awo Osafo-AddoDepartment of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Robert J HomerDepartment of Pathology, Yale School of Medicine, New Haven, Connecticut, USA; and.
Carol Feghali-BostwickDepartment of Medicine, Medical University of South Carolina School of Medicine, Charleston, South Carolina, USA.
Wassim H FaresDepartment of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Mridu GulatiDepartment of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Buqu HuDepartment of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Chun-Geun LeeDepartment of Molecular Microbiology and Immunology, Warren Alpert School of Medicine, Brown University, Providence, Rhode Island, USA.
Jack A EliasDepartment of Molecular Microbiology and Immunology, Warren Alpert School of Medicine, Brown University, Providence, Rhode Island, USA.
Erica L HerzogDepartment of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, USA; erica.herzog@yale.edu.
SleepMed · USBrown University · USMedical University of South Carolina · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Respiratory Computational Discovery CoreP01HL114501 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHOI, MARY E · 2013 to 2025
$24.9M
Training Translational Lung Biology and PathobiologyT32HL007778 · NHLBI · YALE UNIVERSITY · PI Erica L Herzog, NAFTALI KAMINSKI · 1994 to 2026
$14.4M
Lung Genomics Research ConsortiumRC2HL101715 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI GERACI, MARK W, KAMINSKI, NAFTALI · 2009 to 2010
$11.4M
Novel Immunologic Effects of Semaphorin 7a in IPFR01HL109233 · NHLBI · YALE UNIVERSITY · PI HERZOG, ERICA L · 2011 to 2019
$3.7M
Pre-Clinical Development of a Novel Anti-YKL-40 Biologic to Treat Severe AsthmaUH2HL123876 · NHLBI · YALE UNIVERSITY · PI CHUPP, GEOFFREY L, ELIAS, JACK A · 2014 to 2015
$3.3M
YKL-40 in Idiopathic Pulmonary Fibrosis and Kidney TransplantationU01HL108638 · NHLBI · YALE UNIVERSITY · PI ELIAS, JACK A · 2011 to 2014
$2.6M
Gene networks beyond organ boundaries; heart, lung and pulmonary vascular diseaseU01HL108642 · NHLBI · YALE UNIVERSITY · PI AHMAD, FERHAAN, BENOS, PANAGIOTIS V · 2011 to 2014
$2.2M
Neuroimmune Molecules in Scleroderma Lung FibrosisR01HL125850 · NHLBI · YALE UNIVERSITY · PI HERZOG, ERICA L · 2016 to 2019
$1.7M
Chitinase1 as a Biomarker and Therapeutic Target in Scleroderma Lung DiseaseR01HL115813 · NHLBI · BROWN UNIVERSITY · PI LEE, CHUN GEUN · 2014 to 2017
$1.5M
Significance Circulating Semaphorin 7a+ve Cells in Pulmonary SarcoidosisU01HL112702 · NHLBI · YALE UNIVERSITY · PI HERZOG, ERICA L · 2012 to 2014
$488k
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS P01 HL114501NHLBI NIH HHS R01 HL109233NHLBI NIH HHS R01 HL115813NHLBI NIH HHS R01 HL125850NHLBI NIH HHS RC2 HL101715NHLBI NIH HHS T32 HL007778NHLBI NIH HHS U01 HL108638NHLBI NIH HHS U01 HL108642NHLBI NIH HHS U01 HL112702NHLBI NIH HHS UH2 HL123876
6 · The paper itself

Abstract

Pulmonary fibrosis is a progressive and often fatal condition that is believed to be partially orchestrated by macrophages. Mechanisms that control migration of these cells into and within the lung remain undefined. We evaluated the contributions of the semaphorin receptor, plexin C1 (PLXNC1), and the exocytic calcium sensor, synaptotagmin 7 (Syt7), in these processes. We evaluated the role of PLXNC1 in macrophage migration by using Boyden chambers and scratch tests, characterized its contribution to experimentally induced lung fibrosis in mice, and defined the mechanism for our observations. Our findings reveal that relative to control participants, patients with idiopathic pulmonary fibrosis demonstrate excessive monocyte migration and underexpression of PLXNC1 in the lungs and circulation, a finding that is recapitulated in the setting of scleroderma-related interstitial lung disease. Relative to wild type, PLXNC1

Indexed as

AnimalsDisease Models, AnimalHumansLungMacrophagesMice, KnockoutNerve Tissue ProteinsPulmonary FibrosisReceptors, Cell SurfaceReceptors, VirusSynaptotagminsTransforming Growth Factor beta1Nerve Tissue ProteinsPlxna3 protein, mouseReceptors, Cell SurfaceReceptors, VirusSynaptotagminsSyt7 protein, mouseTransforming Growth Factor beta1VESPR semaphorin receptoridiopathic pulmonary fibrosisimmunologyinterstitial lung diseasesclerodermasemaphorin 7a

Identifiers

PMID27609773
PMCPMC5102121
OpenAlexW2509564619

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.